Pragmatic Trial

2

Review clinical trials related to Pragmatic Trial. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study

The goal of this pragmatic clinical trial is to learn if the WE BEAT program, a 5-week group-based online wellbeing and skill-building program, can help teens with congenital heart disease (CHD) improve their ability to handle stress. The main question it aims to answer is if participants who receive the WE BEAT program become more resilient (the ability to bounce back from from tough times or recover from something difficult) and have better quality of life compared to participants who receive usual care. The study also aims to learn if there are connections between participant-reported psychosocial data (such as resilience, feelings about one's life and one's physical, mental, and social wellbeing) and clinical outcomes. Eligible participants who are 12-17-year-old will be in the study for about 6 months and be randomized to receive either the WE BEAT program or usual care. Following completion of the primary WE BEAT intervention at Week 5, intervention arm participants will be randomized to a single-session booster session (occurring at Week 18) vs no booster session. The booster session will be provided in a similar format to the WE BEAT program. A review of all modules/skills introduced in the program will be provided. All participants will complete 4 sets of online surveys and give 3 hair/saliva samples at different timepoints. Some participants may volunteer to give optional blood and urine samples.

Participants needed: 390
Trial details
Age: 12-17Biological sex: AllType: InterventionalSponsor: Carelon ResearchUpdated: Jun 22, 2026Locations: 14
Eligibility criteria

Age 12-17 years old [+4]

CHD of mild or simple complexity (Class I, 2018 AHA/ACC ACHD, Table 4) [+5]

Status: Recruiting

The SaVe Project-Sarcopenia and Vertigo in Aging Patients With Colorectal Cancer

The goal of this clinical trial is to learn about the cause of dizziness and decline in walking ability in in older adults ≥65 years during chemotherapy treatment for colorectal cancer. Another goal is to investigate if a comprehensive geriatric assessment and three months' specialized physical group-based exercise three times/week can counteract muscle weakness, vertigo, instability, impaired walking balance, and neuropathy

Participants needed: 150
Trial details
Age: 65+Biological sex: AllType: InterventionalSponsor: Rigshospitalet, DenmarkUpdated: Apr 6, 2025Locations: 2
Eligibility criteria

Meet the criteria of the oncological departments of receiving neoadjuvant, adjuv... [+3]

Chemotherapy treatment within two years and sequelae of neuropathy, or symptoms... [+4]